CNS-specific peptides & AAV variants
KOREA (July, 2024)
cell-specific peptides & AAV variants (4 ZPs filed)
Korea(February, 2024)
Patent for the treatment of Lafora's disease
KOREA (July, 2023)
Composition for AAV delivery and AAV delivery efficiency screening method
KOREA (June, 2023)
AD/PD/MCI therapeutic agent
KOREA (December, 2017)
USA (July, 2020)
CHINA (June, 2021)
CHINA, PCT(Jun, 2016 )